Fundraising FoxImmunohelix
Seattle, US · 2 known investors
Find your way into Immunohelix
Sign up to find every way you can get introduced to Immunohelix
- Your email: who you already know at Immunohelix, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Immunohelix team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
NapaJen Pharma is a biopharmaceutical research and development company developing nucleic acid (oligonucleotide) drugs using a proprietary cell-specific drug delivery platform that enables delivery to immune cells for precision-targeted immunosuppression and controlled immuno-stimulation. It develops its own drug candidates and partners with other pharmaceutical companies applying its delivery technology.
Founders & leadership
Investors · 2
Frequently asked questions
- What does Immunohelix do?
- NapaJen Pharma is a biopharmaceutical research and development company developing nucleic acid (oligonucleotide) drugs using a proprietary cell-specific drug delivery platform that enables delivery to immune cells for precision-targeted immunosuppression and controlled immuno-stimulation. It develops its own drug candidates and partners with other pharmaceutical companies applying its delivery technology.
- Who founded Immunohelix?
- Immunohelix was founded by Hironori (Randy) Ando.
- Who are Immunohelix's investors?
- Immunohelix's investors include RDiscovery, Remiges Ventures, Inc..
- Where is Immunohelix headquartered?
- Immunohelix is headquartered in Seattle, US.